Faculty Opinions Recommendation of Association of Androgenetic Alopecia with Mortality from Diabetes Mellitus and Heart Disease

June 2013 in “ Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ”

Miloš D. Pavlović

androgenetic alopecia diabetes mellitus heart disease mortality adjusted hazard ratio AGA DM

TLDR People with moderate or severe hair loss are at a higher risk of dying from diabetes and heart disease.

In 2013, a population-based prospective cohort study in Taiwan involving 7252 subjects (4697 women over 30 years old and 2429 men over 40 years old) investigated the association between androgenetic alopecia (AGA) and mortality from diabetes mellitus (DM) and heart disease. The study, which had a response rate of 91.1%, found that during the 5-year follow-up period, 4.64% of the women and 8.48% of the men died. Among subjects aged 50 years or older, those with moderate or severe AGA had a higher mortality rate from DM and heart disease compared to those with normal or mild AGA. The adjusted hazard ratio for mortality from DM and moderate to severe AGA was 2.97, and for mortality from heart disease and moderate to severe AGA was 2.28. The study concluded that AGA could be a significant and easily diagnosed indicator of increased risk of mortality from DM and heart disease, regardless of sex.

View this study on facultyopinions.com →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Convinced dad to get into minox 3 months ago and fin 2 months ago

in Is this regrowth? 825 upvotes 5 months ago

A user convinced their 45-year-old dad to use minoxidil and finasteride, resulting in significant hair regrowth. The dad now uses 1mg of finasteride daily and topical minoxidil twice a day, and has also started using 1% ketoconazole shampoo.

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 4 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community A New Therapeutic Channel to Come Soon: Hair Follicle Sugar Metabolism and Aldose Reductase

in Research/Science 129 upvotes 3 years ago

Hair loss therapies focusing on hair follicle sugar metabolism and aldose reductase. Potential treatments include magnesium supplements, avoiding high glycemic index foods, and antioxidants.

community Hope Medicine announces HMI-115 phase II clinical trial for androgenetic alopecia in China

in Research/Science 58 upvotes 1 year ago

Hope Medicine's announcement of the HMI-115 Phase II clinical trial for androgenetic alopecia in China; other related trials have been conducted or are ongoing in different countries, including Australia, US, and Europe. There is speculation that the product may be accepted across borders without additional testing.

community Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

in Research/Science 88 upvotes 1 year ago

Kintor Pharma completed patient enrollment for a Phase II trial in China for GT20029, a potential new treatment for hair loss. Some believe GT20029 could replace finasteride if effective, while others discuss finasteride's limited efficacy and potential underreported side effects.

community Been using Dutasteride, Ru58841, Minoxidil, and Ketaconozole for years. Still can't stop shed, recession or loss of density.

in Treatment 1 upvotes 2 months ago

Despite using dutasteride, RU58841, minoxidil, and ketoconazole for years, the user continues to experience severe hair loss and thinning. They seek advice after multiple dermatologists confirmed androgenetic alopecia (AGA) but offered no effective solutions.

Similar Research

5 / 1000+ results

research The Association Between Metabolic Syndrome Components and Hair Loss in Both Male and Female Individuals

2 citations, January 2013 in “Hair therapy & transplantation”

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

research Association of Androgenetic Alopecia With Mortality From Diabetes Mellitus and Heart Disease

49 citations, May 2013 in “JAMA Dermatology”

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

research Alopecia and the Metabolic Syndrome

30 citations, September 2017 in “Clinics in Dermatology”

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review

research Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review

June 2023 in “Pharmaceuticals”

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

research COVID-19 and Endocrine and Metabolic Diseases: An Updated Statement from the European Society of Endocrinology

68 citations, May 2021 in “Endocrine”

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.